231 related articles for article (PubMed ID: 26248051)
1. Lithium Modulates Autophagy in Esophageal and Colorectal Cancer Cells and Enhances the Efficacy of Therapeutic Agents In Vitro and In Vivo.
O'Donovan TR; Rajendran S; O'Reilly S; O'Sullivan GC; McKenna SL
PLoS One; 2015; 10(8):e0134676. PubMed ID: 26248051
[TBL] [Abstract][Full Text] [Related]
2. Prodigiosin impairs autophagosome-lysosome fusion that sensitizes colorectal cancer cells to 5-fluorouracil-induced cell death.
Zhao C; Qiu S; He J; Peng Y; Xu H; Feng Z; Huang H; Du Y; Zhou Y; Nie Y
Cancer Lett; 2020 Jul; 481():15-23. PubMed ID: 32184145
[TBL] [Abstract][Full Text] [Related]
3. Chrysin Attenuates Cell Viability of Human Colorectal Cancer Cells through Autophagy Induction Unlike 5-Fluorouracil/Oxaliplatin.
Lin YM; Chen CI; Hsiang YP; Hsu YC; Cheng KC; Chien PH; Pan HL; Lu CC; Chen YJ
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899208
[TBL] [Abstract][Full Text] [Related]
4. UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells.
Falvey CM; O'Donovan TR; El-Mashed S; Nyhan MJ; O'Reilly S; McKenna SL
Oncotarget; 2017 Apr; 8(14):23479-23491. PubMed ID: 28186990
[TBL] [Abstract][Full Text] [Related]
5. Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer.
Chen YQ; Zhu WT; Lin CY; Yuan ZW; Li ZH; Yan PK
Int J Nanomedicine; 2021; 16():269-281. PubMed ID: 33469286
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
Nukatsuka M; Nakagawa F; Takechi T
Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
[TBL] [Abstract][Full Text] [Related]
7. EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells.
Hu F; Wei F; Wang Y; Wu B; Fang Y; Xiong B
J Pharmacol Sci; 2015 May; 128(1):27-34. PubMed ID: 26003085
[TBL] [Abstract][Full Text] [Related]
8. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.
Shi Y; Han Y; Xie F; Wang A; Feng X; Li N; Guo H; Chen D
J Cell Mol Med; 2015 Mar; 19(3):535-43. PubMed ID: 25534115
[TBL] [Abstract][Full Text] [Related]
9. Autophagy facilitates anticancer effect of 5-fluorouracil in HCT-116 cells.
Yang JW; Zhang QH; Liu T
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1141-S1147. PubMed ID: 30539860
[TBL] [Abstract][Full Text] [Related]
10. Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells.
Hong EH; Heo EY; Song JH; Kwon BE; Lee JY; Park Y; Kim J; Chang SY; Chin YW; Jeon SM; Ko HJ
Oncotarget; 2017 Jun; 8(25):41401-41411. PubMed ID: 28489607
[TBL] [Abstract][Full Text] [Related]
11. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment.
Yang HZ; Ma Y; Zhou Y; Xu LM; Chen XJ; Ding WB; Zou HB
Cancer Lett; 2015 May; 361(1):128-36. PubMed ID: 25749420
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of autophagy enhances synergistic effects of Salidroside and anti-tumor agents against colorectal cancer.
Li H; Chen C
BMC Complement Altern Med; 2017 Dec; 17(1):538. PubMed ID: 29246220
[TBL] [Abstract][Full Text] [Related]
13. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
Fioravanti A; Canu B; Alì G; Orlandi P; Allegrini G; Di Desidero T; Emmenegger U; Fontanini G; Danesi R; Del Tacca M; Falcone A; Bocci G
Eur J Pharmacol; 2009 Oct; 619(1-3):8-14. PubMed ID: 19695243
[TBL] [Abstract][Full Text] [Related]
14. Capsaicin Enhances the Drug Sensitivity of Cholangiocarcinoma through the Inhibition of Chemotherapeutic-Induced Autophagy.
Hong ZF; Zhao WX; Yin ZY; Xie CR; Xu YP; Chi XQ; Zhang S; Wang XM
PLoS One; 2015; 10(5):e0121538. PubMed ID: 25933112
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cells.
Xavier CP; Lima CF; Pedro DF; Wilson JM; Kristiansen K; Pereira-Wilson C
J Nutr Biochem; 2013 Apr; 24(4):706-12. PubMed ID: 22841540
[TBL] [Abstract][Full Text] [Related]
16. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
Ding ZB; Hui B; Shi YH; Zhou J; Peng YF; Gu CY; Yang H; Shi GM; Ke AW; Wang XY; Song K; Dai Z; Shen YH; Fan J
Clin Cancer Res; 2011 Oct; 17(19):6229-38. PubMed ID: 21825039
[TBL] [Abstract][Full Text] [Related]
17. The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells.
Nyhan MJ; O'Donovan TR; Elzinga B; Crowley LC; O'Sullivan GC; McKenna SL
Br J Cancer; 2012 Feb; 106(4):711-8. PubMed ID: 22240779
[TBL] [Abstract][Full Text] [Related]
18. Autophagy regulates Selumetinib (AZD6244) induced-apoptosis in colorectal cancer cells.
Grasso S; Pereira GJS; Palmeira-Dos-Santos C; Calgarotto AK; Martínez-Lacaci I; Ferragut JA; Smaili SS; Bincoletto C
Eur J Med Chem; 2016 Oct; 122():611-618. PubMed ID: 27448918
[TBL] [Abstract][Full Text] [Related]
19. MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cells.
Nyhan MJ; O'Donovan TR; Boersma AW; Wiemer EA; McKenna SL
BMC Cancer; 2016 Feb; 16():101. PubMed ID: 26878873
[TBL] [Abstract][Full Text] [Related]
20. BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells.
Goulielmaki M; Koustas E; Moysidou E; Vlassi M; Sasazuki T; Shirasawa S; Zografos G; Oikonomou E; Pintzas A
Oncotarget; 2016 Feb; 7(8):9188-221. PubMed ID: 26802026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
